Pharmaceutics International, Inc. (Pii), a CDMO headquartered in Hunt Valley, MD, in partnership with Athenex Pharmaceuticals, Sungen Pharma and Chemwerth, have launched Busulfan Injection, 6mg/mL in 10mL vials.  Pii is responsible for all commercial production and Athenex will market and distribute the product in the U.S. Busulfan Injection is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for ch...